These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 19021293)

  • 21. Aβ-degrading enzymes: potential for treatment of Alzheimer disease.
    Miners JS; Barua N; Kehoe PG; Gill S; Love S
    J Neuropathol Exp Neurol; 2011 Nov; 70(11):944-59. PubMed ID: 22002425
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuronal neprilysin overexpression is associated with attenuation of Abeta-related spatial memory deficit.
    Poirier R; Wolfer DP; Welzl H; Tracy J; Galsworthy MJ; Nitsch RM; Mohajeri MH
    Neurobiol Dis; 2006 Dec; 24(3):475-83. PubMed ID: 17008108
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activating AhR alleviates cognitive deficits of Alzheimer's disease model mice by upregulating endogenous Aβ catabolic enzyme Neprilysin.
    Qian C; Yang C; Lu M; Bao J; Shen H; Deng B; Li S; Li W; Zhang M; Cao C
    Theranostics; 2021; 11(18):8797-8812. PubMed ID: 34522212
    [No Abstract]   [Full Text] [Related]  

  • 24. Aging-related down-regulation of neprilysin, a putative beta-amyloid-degrading enzyme, in transgenic Tg2576 Alzheimer-like mouse brain is accompanied by an astroglial upregulation in the vicinity of beta-amyloid plaques.
    Apelt J; Ach K; Schliebs R
    Neurosci Lett; 2003 Mar; 339(3):183-6. PubMed ID: 12633883
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Understanding molecular mechanisms of proteolysis in Alzheimer's disease: progress toward therapeutic interventions.
    Higuchi M; Iwata N; Saido TC
    Biochim Biophys Acta; 2005 Aug; 1751(1):60-7. PubMed ID: 16054018
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 5-HIAA induces neprilysin to ameliorate pathophysiology and symptoms in a mouse model for Alzheimer's disease.
    Klein C; Roussel G; Brun S; Rusu C; Patte-Mensah C; Maitre M; Mensah-Nyagan AG
    Acta Neuropathol Commun; 2018 Dec; 6(1):136. PubMed ID: 30537985
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Major amyloid-β-degrading enzymes, endothelin-converting enzyme-2 and neprilysin, are expressed by distinct populations of GABAergic interneurons in hippocampus and neocortex.
    Pacheco-Quinto J; Eckman CB; Eckman EA
    Neurobiol Aging; 2016 Dec; 48():83-92. PubMed ID: 27644077
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression and functional profiling of neprilysin, insulin-degrading enzyme, and endothelin-converting enzyme in prospectively studied elderly and Alzheimer's brain.
    Wang S; Wang R; Chen L; Bennett DA; Dickson DW; Wang DS
    J Neurochem; 2010 Oct; 115(1):47-57. PubMed ID: 20663017
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Loss of neprilysin function promotes amyloid plaque formation and causes cerebral amyloid angiopathy.
    Farris W; Schütz SG; Cirrito JR; Shankar GM; Sun X; George A; Leissring MA; Walsh DM; Qiu WQ; Holtzman DM; Selkoe DJ
    Am J Pathol; 2007 Jul; 171(1):241-51. PubMed ID: 17591969
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intramuscular delivery of p75NTR ectodomain by an AAV vector attenuates cognitive deficits and Alzheimer's disease-like pathologies in APP/PS1 transgenic mice.
    Wang QH; Wang YR; Zhang T; Jiao SS; Liu YH; Zeng F; Li J; Yao XQ; Zhou HD; Zhou XF; Wang YJ
    J Neurochem; 2016 Jul; 138(1):163-73. PubMed ID: 26991827
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neprilysin gene transfer: A promising therapeutic approach for Alzheimer's disease.
    Li Y; Wang J; Zhang S; Liu Z
    J Neurosci Res; 2015 Sep; 93(9):1325-9. PubMed ID: 26096375
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of neprilysin in skeletal muscle reduces amyloid burden in a transgenic mouse model of Alzheimer disease.
    Liu Y; Studzinski C; Beckett T; Guan H; Hersh MA; Murphy MP; Klein R; Hersh LB
    Mol Ther; 2009 Aug; 17(8):1381-6. PubMed ID: 19471248
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neprilysin-2 is an important β-amyloid degrading enzyme.
    Hafez D; Huang JY; Huynh AM; Valtierra S; Rockenstein E; Bruno AM; Lu B; DesGroseillers L; Masliah E; Marr RA
    Am J Pathol; 2011 Jan; 178(1):306-12. PubMed ID: 21224067
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness of Combinational Treatments for Alzheimer's Disease with Human Neural Stem Cells and Microglial Cells Over-Expressing Functional Genes.
    Ban YH; Park D; Choi EK; Kim TM; Joo SS; Kim YB
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298510
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular basis of selective amyloid-β degrading enzymes in Alzheimer's disease.
    Żukowska J; Moss SJ; Subramanian V; Acharya KR
    FEBS J; 2024 Jul; 291(14):2999-3029. PubMed ID: 37622248
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cell surface expression of the major amyloid-β peptide (Aβ)-degrading enzyme, neprilysin, depends on phosphorylation by mitogen-activated protein kinase/extracellular signal-regulated kinase kinase (MEK) and dephosphorylation by protein phosphatase 1a.
    Kakiya N; Saito T; Nilsson P; Matsuba Y; Tsubuki S; Takei N; Nawa H; Saido TC
    J Biol Chem; 2012 Aug; 287(35):29362-72. PubMed ID: 22767595
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Accumulation of murine amyloid-β mimics early Alzheimer's disease.
    Krohn M; Bracke A; Avchalumov Y; Schumacher T; Hofrichter J; Paarmann K; Fröhlich C; Lange C; Brüning T; von Bohlen Und Halbach O; Pahnke J
    Brain; 2015 Aug; 138(Pt 8):2370-82. PubMed ID: 25991605
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Effect of Chronic Cerebral Hypoperfusion on Amyloid-β Metabolism in a Transgenic Mouse Model of Alzheimer's Disease (PS1V97L).
    Yang H; Hou T; Wang W; Luo Y; Yan F; Jia J
    J Alzheimers Dis; 2018; 62(4):1609-1621. PubMed ID: 29614686
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A butyrolactone derivative 3BDO alleviates memory deficits and reduces amyloid-β deposition in an AβPP/PS1 transgenic mouse model.
    Wei L; Yang H; Xie Z; Yang S; Yang H; Zhao C; Wang P; Xu S; Miao J; Zhao B; Bi J
    J Alzheimers Dis; 2012; 30(3):531-43. PubMed ID: 22451314
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neprilysin deficiency-dependent impairment of cognitive functions in a mouse model of amyloidosis.
    Mohajeri MH; Wolfer DP
    Neurochem Res; 2009 Apr; 34(4):717-26. PubMed ID: 19199031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.